Who owns the RESTILON trademark?

The RESTILON trademark is owned by Billings Pharmaceutical, Inc..

What is the serial number for RESTILON?

The USPTO serial number for RESTILON is 75302266.

What is the registration number for RESTILON?

RESTILON is registered under USPTO registration number 0.

RES

USPTO Trademark Record

ABANDONED

RESTILON

Q: What class is the RESTILON trademark registered in?

The RESTILON trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 75302266·Reg 0·Filed Jun 02, 1997

Owner Billings Pharmaceutical, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

RESTILON (Serial No. 75302266), Registration No. 0, is a abandoned US trademark filed on Jun 02, 1997 by Billings Pharmaceutical, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

RESTILON (Reg. #0) is an abandoned US trademark that was filed in 1997 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 02, 1997

SERIAL

75302266

REG#

Owner

Applicant

Billings Pharmaceutical, Inc.

Entity

Corporation

State

Address

2440 North Lakeview Avenue, Chicago, IL, 60614

Country

Attorney

NameLEWIS D HANSEN

Law firm

LEWIS D HANSEN SHERIDAN ROSS PC

Docket

3502.21

Address

1700 LINCOLN ST STE 3500, DENVER, CO 80203, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJun 02, 1997

Serial Number75302266

Registration No.0

Status DateDec 04, 1998

Published for OppositionMay 19, 1998

Mark TypeTypeset (words/letters/numbers)

Attorney Docket3502.21

Status DescriptionDead and abandoned due to express abandonment after publication

Filing Signals

FILED

1997

YEARS AGO

29y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

8 events

ABANDONMENT - AFTER PUBLICATION

Dec 04, 1998

ABANDONMENT - AFTER PUBLICATION

EXTENSION OF TIME TO OPPOSE RECEIVED

Jun 16, 1998

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

May 19, 1998

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Apr 17, 1998

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 23, 1998

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT MAILED

Mar 18, 1998

EXAMINER'S AMENDMENT MAILED

NON-FINAL ACTION MAILED

Feb 03, 1998

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Jan 06, 1998

ASSIGNED TO EXAMINER

RESTILON

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Billings Pharmaceutical, Inc.

Other Marks by LEWIS D HANSEN

Resources

Company